The practice of precision medicine will change the provision of healthcare in Australia. Precision medicine, digital technologies and their applications are already changing clinical practice and over the next 5 to 10 years many of these will become standard practice in healthcare. Ensuring that these rapidly evolving advances are integrated into the healthcare system with foresight and strategic intent is critical to delivering better health outcomes to all Australians.
GenomePlus applies a person-centric approach, built on co-creation methodologies, to collaborate across the healthcare system to integrate precision medicine, advanced therapies and new innovative technologies into industry and clinical practice.
Central to the future delivery of Precision Medicine is a confident and capable workforce. GenomePlus provides a unique approach to identifying workforce needs and gaps and upskilling staff with the capabilities and 21st-century skills needed to accelerate access of advanced therapeutics and new technologies to patients.
Through consultation and collaboration, GenomePlus partners with organisations to build a confident and capable workforce and deliver strategic projects through the authentic inclusion of patient advocacy and support groups needs and insights.
services
GenomePlus partners and collaborates with a network of academic, research, industry, and consumer groups from Australia and internationally to provide clients with independent consultation services.
Patient-Centric Collaboration: GenomePlus works with patient advocacy and support groups providing co-create workshops, planning, and strategic project development, as well as, mentoring to build transparent, equal, and collaborative relationships with the industry.
Industry and Patient Group Mentoring & Partnerships: Genomeplus provides mentoring services to Industry to support equal and transparent engagement with patient advocacy and support groups.
Workforce Capabilities Planning and Implementation: GenomePlus provides a platform to identify needs and gaps across the workforce and curates independent content tailored to the client’s needs to put precision health into context for their specific business needs. The platform uses Horizon Scanning methodology to remain at the forefront of technology, includes deep insights on the delivery and commissioning of care, and ensures learnings are successfully integrated into business practice through change management principles. GenomePlus has collaborations with Australian and international industry experts, academics, specialist clinicians, researchers, and educators to ensure a personalised, accurate, and flexible program is developed for the company, allied health service, or state department.
We provide these services to the Medical Technology and Pharmaceutical Industries, Allied Health professionals, Patient Support and Advocacy groups, as well as industries such as banking, insurance, and finance where understanding the impact of genomics, precision medicine and digital health is relevant to work practice and investment assessment.
